N	Concordance
1	sphamide, cytosine arabinoside, and CNS prophylaxis with methotrexate. Although 
2	 modified doses of chemotherapy and CNS prophylaxis have given complete remissio
3	ould probably have chemotherapeutic CNS prophylaxis repeated to prevent recurren
4	 tous meningitis receive concurrent CNS prophylaxis/therapy on Regimen B.  The f
5	ed during induction, consolidation, CNS prophylaxis, and any intensive  aspect o
6	rrent goal is to  achieve effective CNS prophylaxis while minimizing neurotoxici
7	 er 3 cycles a patient may be given CNS prophylaxis with triple intrathecal ther
8	 With a previous protocol including CNS prophylaxis, 40% of our adult patients a
9	three phases:  remission induction, CNS prophylaxis, and remission continuation
10	  sinus  or testicular involvement. CNS prophylaxis for bone marrow involvement 
11	 d to Arm II.  All patients receive CNS prophylaxis with IT ARA-C. The followin
12	ed for leukemia or NHL who received CNS prophylaxis with cranial irradiation (n 
13	nsive combination chemotherapy with CNS prophylaxis is the standard treatment o
14	f adequate central nervous system (CNS) prophylaxis is  critical in achieving co